Arby Leonian is the passionate Swedish-Armenian co-founder of the HealthTech business Thermaiscan. The company operates within predictive medicine, currently developing a breast cancer
pre-screening solution based on AI and thermal sensors in smartphones, for healthcare units. Arby
has a background in digital business, pedagogy, healthcare and firefighting. Around 2016, he dived
into the IT sector, studying Digital Business at Hyper Island School in Stockholm. After Hyper Island
the aim was clear: to make a real impact using digital tools. Since then, most of his focus has been on
digital business and product development within AI and the blockchain industry. Arby met the founder
& thermal expert of Thermaiscan in May 2019, and suddenly he could see the future around the
corner: how much a breast cancer pre-screening solution would make difference and save lives.
Without hesitation, Arby joined the mission to solve the problem with late detection of breast cancer
development.
Day 1 - 17 October 2022
Time |
Session |
|
14:00
16:00
|
The R&D to commercialisation route for digital health solutions are very challenging. How do aspiring Nordic innovators and researchers minimise risks to ensure higher chances of commercial success? A Case-Sharing session by the Nordic Companies on their journey to success
-
Early detection of breast cancer with cutting edge technology
-
Automated individual analysis and decision support for diabetes teams and patients
-
Innovative and affordable solutions that enable effective diabetes and cancer screening
-
A reliable solution for arrhythmia monitoring no matter where you are
-
Cost-effective sensors that enable continuous monitoring of patients at home
-
Transforming the screening and management of diabetic eye disease
-
Panel Discussion
|